What Has Been The Historical And Current Growth Of The RNA Analysis/ Transcriptomics Market?
The rna analysis/ transcriptomics market has seen considerable growth due to a variety of factors.
• The market size of RNA analysis/ transcriptomics has experienced swift expansion in the last few years. The market, which was worth $7.72 billion in 2024 is anticipated to yield a value of $8.8 billion in 2025, increasing at an impressive compound annual growth rate (CAGR) of 14.1%.
The driving factors behind this substantial growth during the historic period can be traced back to advancements in cancer research and precision medicine, drug invention and progression, infectious disease diagnosis, custom-tailored medicine, as well as educational and governmental funding, coupled with a surge in applications within the agricultural sector.
What Is The Forecast For The RNA Analysis/ Transcriptomics Market By 2029?
The rna analysis/ transcriptomics market is expected to maintain its strong growth trajectory in upcoming years.
• The market for RNA analysis/ transcriptomics is anticipated to grow significantly in the upcoming years, reaching a value of $16.54 billion in 2029 with a compound annual growth rate (CAGR) of 17.1%.
This progression during the forecast period can be attributed to factors such as the application of single-cell RNA sequencing, the incorporation of RNA analysis into clinical diagnostics, RNA-based therapies and vaccinations, bioinformatics and tools for data analysis, as well as the discovery and validation of biomarkers. The forecast period is expected to see major trends like spatial transcriptomics and in situ RNA analysis, long-read RNA sequencing technologies, RNA editing and modification analysis, the application of AI in RNA data analysis, RNA treatments for uncommon diseases, and RNA-based liquid biopsy for cancer diagnosis.
Which Key Drivers Are Propelling The RNA Analysis/ Transcriptomics Market's Growth?
The anticipated rise in personalized medicine is foreseen to propel the expansion of the RNA analysis/transcriptomics market in future years. Personalized medicine involves tailoring medical treatments to suit the unique characteristics of each individual patient. RNA-Seq is expected to manage the projected large-scale clinical requirements if scientists can apply the necessary systems and procedures for individualized clinical care. For example, the Personalized Medicine Coalition (PMC), a U.S.-based entity that encourages the comprehension and assimilation of personalized medicine, stated in October 2022 that over 75,000 genetic test products and 300 personalized medicines for various types of cancer, rare genetic diseases, and a variety of chronic and infectious diseases will be accessible in the market. Consequently, the escalating demand for personalized medicines is fostering the growth of the RNA analysis market.
What Are The Key Segments Within The Global RNA Analysis/ Transcriptomics Market?
The RNA analysis/ transcriptomics market covered in this report is segmented –
1) By Product: Reagents/Consumables, Instruments, Software
2) By Technology, Microarrays, Sequencing, Polymerase Chain Reaction RNA Interference
3) By Application: Clinical Diagnostics, Drug Discovery, Toxicogenomics, Comparative Transcriptomics, RNA Interference
Subsegments:
1) By Reagents/Consumables: Nucleotides, Enzymes, Buffers and Solutions, Sample Preparation Kits, Sequencing Kits
2) By Instruments: Sequencers, Real-Time PCR Machines, Microarrays, Electrophoresis Systems, Robotic Liquid Handlers
3) By Software: Data Analysis Software, Bioinformatics Tools, Statistical Analysis Software, Visualization Software, Database Management Systems
Pre-Book The RNA Analysis/ Transcriptomics Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The RNA Analysis/ Transcriptomics Market?
Innovations and advancements in technology are becoming a rising trend in the RNA analysis/transcriptomics market. Techniques like next-generation sequencing (NGS) and RNA interference (RNAi) have enhanced precision and accuracy, aiding researchers in analyzing transcriptional activity. For example, Illumina's next-generation sequencing is utilized effectively in breaking down DNA/RNA into many pieces, appending adapters, sequencing the libraries, and reconstructing them to create a genomic sequence.
Who Are the Key Players in the RNA Analysis/ Transcriptomics Market?
Major companies operating in the RNA analysis/ transcriptomics market include:
• Affymetrix Inc.
• Agilent Technologies Inc.
• Bio-Rad Laboratories Inc.
• GE Healthcare
• Illumina Inc.
• QIAGEN N.V.
• F. Hoffmann-La Roche Ltd.
• Sigma-Aldrich Corporation
• Thermo Fisher Scientific Inc.
• Fluidigm Corporation
• Promega Corporation
• bioMérieux S.A.
• CD Genomics Inc.
• Eurofins Scientific SE
• Merck KGaA
• Pacific Biosciences of California Inc.
• Danaher Corporation
• Genewiz Inc.
• Oxford Nanopore Technologies Ltd.
• BGI Group
• Genotypic Technology Pvt. Ltd.
• MedGenome Labs Pvt. Ltd.
• Xcelris Labs Ltd.
• Ocimum Biosolutions Ltd.
• Strand Life Sciences Pvt. Ltd.
• SciGenom Labs Pvt. Ltd.
• Oncocyte Corporation
• Tempus Labs Inc.
• ArcherDX Inc.
• HTG Molecular Diagnostics Inc.
What are the Regional Insights into the RNA Analysis/ Transcriptomics Market?
North America was the largest region in the RNA analysis/transcriptomics market in 2024. This region is expected to be the fastest-growing region in the forecast period. The regions covered in the RNA analysis/ transcriptomics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
